Company intelligence / Profile preview
Sclnow Biotechnology Co., Ltd.
Beijing, Beijing Shi, Chinancbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
The company focuses heavily on developing allogeneic human umbilical cord-derived mesenchymal stem cell therapies targeting degenerative diseases such as osteoarthritis, female infertility-related conditions, liver cirrhosis caused by hepatitis B infection, wounds healing, intervertebral disc degeneration among others. Their most advanced program reached Phase III in wound healing. However, some early-stage trials have been halted recently due to lack of funding. They also operate proprietary biobanking and big data platforms supporting regenerative medicine research[1][2][3][4][7].
- Therapeutic areas
- GastroenterologyCardiovascularRheumatologyOtherWomen's HealthNeurology
- Modalities
- Mesenchymal stem cell therapy (MSC)Cell replacement therapiesRegenerative medicine products including umbilical cord-derived MSCs
- Industry
- Biotech
02
Drug pipeline
18 assets17 more assets in the full pipeline.
Request access →03
Partnerships
No major pharmaceutical partnerships publicly disclosed but collaborations with academic institutions such as Chinese Academy of Sciences exist[5].Also involved with thousands of doctors through alliances focusing on MSCs and pain/regenerative medicine[2].
Beyond the preview
Go deeper on Sclnow Biotechnology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sclnow Biotechnology Co., Ltd..